Tocolytics are short-term treatments used to allow time for interventions that can improve the outcomes of preterm labor and delivery for both mother and child. Since no single tocolytic drug is ...

Department of Medicine, McGill University Health Center Research Institute, Montréal H3A 1A1, Québec, Canada Department of Pharmacology and Therapeutics, McGill University, Montréal H3G 1Y6, Québec, ...

• All tocolytics (medicines that delay labour) that we assessed (betamimetics, calcium channel blockers, magnesium sulphate, oxytocin receptor antagonists, nitric oxide donors) and their combinations ...

In honor of Women’s Health Month, reproductive health researcher and Assistant Professor Scott Barnett from the Department of Biochemistry & Molecular Biology shares the sobering reality of the rising ...

Researchers have found that while the tocolytic drug atosiban prolonged labor in cases of threatened preterm birth beyond 30 weeks, it did not improve neonatal outcomes compared to a placebo. They ...

The contraction inhibitor atosiban (Tractocile) was no better than placebo for neonatal outcomes in the context of threatened preterm birth, the investigators in the multicenter, randomized, ...

AURORA, Colo. -- Atosiban, an oxytocin receptor antagonist available in Europe, was not superior to placebo in improving neonatal outcomes for threatened preterm birth between 30 and 34 weeks' ...

Preterm birth, occurring before 37 weeks of pregnancy, affects a significant number of infants globally. Various factors, including lifestyle choices, medical conditions, and pregnancy complications, ...

Vanderbilt University Medical Center is receiving $3.3 million over two years through the Advanced Research Projects Agency for Health's (ARPA-H) Sprint for Women's Health for its early-stage research ...